IN2013CH04473A - - Google Patents

Info

Publication number
IN2013CH04473A
IN2013CH04473A IN4473CH2013A IN2013CH04473A IN 2013CH04473 A IN2013CH04473 A IN 2013CH04473A IN 4473CH2013 A IN4473CH2013 A IN 4473CH2013A IN 2013CH04473 A IN2013CH04473 A IN 2013CH04473A
Authority
IN
India
Prior art keywords
pharmaceutically acceptable
acceptable excipients
active layer
layer
telmisartan
Prior art date
Application number
Other languages
English (en)
Inventor
Eswara Gopala Krishna Murthy Dr Talasila
Ravi Sankar Kothamasu
Original Assignee
Eswara Gopala Krishna Murthy Dr Talasila
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eswara Gopala Krishna Murthy Dr Talasila filed Critical Eswara Gopala Krishna Murthy Dr Talasila
Priority to IN4473CH2013 priority Critical patent/IN2013CH04473A/en
Publication of IN2013CH04473A publication Critical patent/IN2013CH04473A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IN4473CH2013 2013-10-01 2013-10-01 IN2013CH04473A (enExample)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN4473CH2013 IN2013CH04473A (enExample) 2013-10-01 2013-10-01

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN4473CH2013 IN2013CH04473A (enExample) 2013-10-01 2013-10-01

Publications (1)

Publication Number Publication Date
IN2013CH04473A true IN2013CH04473A (enExample) 2015-04-10

Family

ID=54398311

Family Applications (1)

Application Number Title Priority Date Filing Date
IN4473CH2013 IN2013CH04473A (enExample) 2013-10-01 2013-10-01

Country Status (1)

Country Link
IN (1) IN2013CH04473A (enExample)

Similar Documents

Publication Publication Date Title
EP4249055A3 (en) Tofacitinib oral sustained release dosage forms
IL271420A (en) Methods of encapsulating single cells, the encapsulated cells and uses thereof
MX2016001424A (es) Composiciones edulcorantes.
PH12015502755A1 (en) Insulin glargine / lixisenatide fixed ratio formulation
PH12017501084A1 (en) Insulin glargine/lixisenatide fixed ratio formulation
MX367210B (es) Soluciones orales estables para api combinados.
MY176793A (en) Pharmaceutical tablet comprising acetylsalicylic acid and clopidogrel
EA201201202A1 (ru) Пероральная фармацевтическая композиция, содержащая этексилат дабигатрана
WO2014114255A3 (zh) 一种定位速释生物粘附剂及应用
EA201400737A1 (ru) Система доставки на основе множества пеллет с немедленным высвобождением активного вещества
AU2018300075A1 (en) Dual release dosage form capsule and methods, devices and systems for making same
PH12015500165A1 (en) Formulations and methods of manufacturing formulations for use in colonic evacuation
MX2019004554A (es) Forma de dosis farmaceutica de capsula de gelatina blanda con goma guar modificada.
EA201891886A1 (ru) Содержащая прегабалин трехслойная таблетка с замедленным высвобождением для перорального приема
EP3485877A4 (en) EXTENDED RELEASE GRANULE WITH TAMSULOSINE HYDROCHLORIDE.
GB2543709A (en) Pharmaceutical agent
IN2013CH04473A (enExample)
WO2016108507A3 (ko) 멜라토닌 및 설트랄린을 포함하는 경구용 복합정제
EP3065737A4 (en) Oral pharmaceutical form for preventing vascular diseases, tablet as pharmaceutical form and gelatin capsule as pharmaceutical form
WO2015108499A3 (en) Therapeutic implantable device
IN2013MU02015A (enExample)
张树勇 First Female Amputee Climbing Mount Everest
王娟 The Contrastive Multimodal Study between Chinese and Western Movie Posters
EA201891885A1 (ru) Содержащая прегабалин высоконабухаемая трехслойная таблетка с замедленным высвобождением для перорального приема
顾曰国 A Whole Person